Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson's disease.
about
Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Pharmacokinetic drug evaluatio ...... ate stage Parkinson's disease.
@en
Pharmacokinetic drug evaluatio ...... ate stage Parkinson's disease.
@nl
type
label
Pharmacokinetic drug evaluatio ...... ate stage Parkinson's disease.
@en
Pharmacokinetic drug evaluatio ...... ate stage Parkinson's disease.
@nl
prefLabel
Pharmacokinetic drug evaluatio ...... ate stage Parkinson's disease.
@en
Pharmacokinetic drug evaluatio ...... ate stage Parkinson's disease.
@nl
P2860
P1476
Pharmacokinetic drug evaluatio ...... ate stage Parkinson's disease.
@en
P2860
P304
P356
10.1080/17425255.2017.1329418
P407
P577
2017-06-01T00:00:00Z